title: Exhaled nitric oxide in acute respiratory syncytial virus bronchiolitis.
abstract: OBJECTIVE
  To investigate fractional exhaled nitric oxide (FeNO) levels in infants during acute respiratory syncytial virus (RSV) bronchiolitis and during convalescence.
  
  
  METHODS
  Prospective cohort study. Comparison of FeNO levels between infants with laboratory-confirmed acute RSV bronchiolitis and 2 control groups: healthy infants and infants with recurrent wheezing.
  
  
  METHODS
  The Department of Pediatric Emergency Medicine and the Pediatric Pulmonary Clinic of the Tel Aviv Medical Center from November 2008 to July 2009. The FeNO levels were measured at referral and at 2 visits over 4 months after convalescence. The FeNO level was measured using the multiple-breath exhalation technique.
  
  
  METHODS
  Forty-four infants with acute RSV bronchiolitis (mean [SD] age, 6.8 [7.3] months), 21 infants with recurrent wheezing (mean [SD] age, 10.8 [7.59] months), and 32 age-matched healthy controls (mean [SD] age, 6.8 [9.1] months). Follow-up data were available for 22 children (55%) for the first follow-up visit and for 11 children (25%) for the second follow-up visit.
  
  
  METHODS
  Acute RSV bronchiolitis.
  
  
  METHODS
  The FeNO levels during acute RSV bronchiolitis vs controls and FeNO levels during follow-up vs acute-stage disease.
  
  
  RESULTS
  Mean FeNO levels for RSV-positive infants were significantly lower compared with healthy controls and infants with recurrent wheezing: mean (SD), 1.89 (1.76) parts per billion (ppb), 7.28 (4.96) ppb, and 4.86 (7.49) ppb, respectively (P<.001). The FeNO levels at the 2- and 4-month follow-up visits increased to 7.74 (5.13) ppb and 11.37 (6.29) ppb, respectively (P=.001).
  
  
  CONCLUSIONS
  The FeNO levels are temporarily reduced during acute RSV bronchiolitis and increase during convalescence to normal levels and higher. The mechanisms for this suppression and its relation to future wheezing and asthma need to be studied.
authors.affiliation: Department of Pediatric Pulmonology, Critical Care, and Sleep Medicine, Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv University, 6 Weizman St, Tel Aviv 64239, Israel.
authors.forename: Tal
authors.initials: T
authors.lastname: Gadish
authors.forename: Ruth
authors.initials: R
authors.lastname: Soferman
authors.forename: Tamar
authors.initials: T
authors.lastname: Merimovitch
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Fireman
authors.forename: Yakov
authors.initials: Y
authors.lastname: Sivan
mesh_terms: D000208:Acute Disease; D001944:Breath Tests; D001990:Bronchiolitis, Viral / Q000378:metabolism*; D003289:Convalescence; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009569:Nitric Oxide / Q000032:analysis / Q000378:metabolism*; D011446:Prospective Studies; D012135:Respiratory Sounds; D018357:Respiratory Syncytial Virus Infections / Q000378:metabolism*; D018113:Respiratory Syncytial Virus, Human
chemical_list: D009569:Nitric Oxide